Indoco Remedies Limited has informed the Exchange regarding a press release dated May 16, 2024, titled "USFDA successfully completes inspection at Indoco s API Kilo Lab manufacturing facility and IAS division without any observations".
Indoco Remedies Limited has informed the Exchange regarding a press release dated May 16, 2024, titled "USFDA successfully completes inspection at Indoco s API Kilo Lab manufacturing facility and IAS division without any observations".